Read on »
~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Saturday, October 31, 2015
Cannabis-Derived Sativex for MS-Related Spasticity Reported to Be Effective and Safe
Spray is only pharmaceutical derived from cannabinoids approved to treat spasticity symptoms in multiple sclerosis
Barcelona, Spain-based, global pharma firm Almirall presented new clinical evidence at the31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) — held in Barcelona October 7–10, 2015 — supporting the efficacy of its Sativex product, currently the only pharmaceutical medicine derived from cannabinoids to treat spasticity symptoms in multiple sclerosis (MS). Experts attending discussed various aspects of the disease, including spasticity’s impact on patients’ quality of life, and the specifics of its treatment with Sativex.
Read on »
MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide
by signing up by clicking here